These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37941905)

  • 21. Clinical risk prediction model and external validation of positive surgical margin in laparoscopic radical prostatectomy based on MRI lesion location.
    Chen X; Wang C; Chen Y; Qian C; Huang R; Bao J; Lin Y; Hou J; Huang Y; Wei X
    Clin Transl Oncol; 2024 Aug; 26(8):1998-2005. PubMed ID: 38472559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Location of positive surgical margin and its association with biochemical recurrence rate do not differ significantly in four different types of radical prostatectomy.
    Suh YS; Jang HJ; Song W; Lee HW; Kim HS; Jeon HG; Jeong BC; Seo SI; Jeon SS; Choi HY; Lee HM
    Korean J Urol; 2014 Dec; 55(12):802-7. PubMed ID: 25512814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Neoadjuvant hormonal therapy versus surgery alone for radical prostatectomy in high-risk prostate cancer patients].
    Kobayashi M; Saito Y; Komaru A; Fukasawa S; Suyama T; Akakura K; Ichikawa T; Ueda T
    Hinyokika Kiyo; 2013 Jul; 59(7):411-8. PubMed ID: 23945319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Centralized prostatectomy with intraoperative NeuroSAFE margin assessment improves surgical margin control.
    Kroon LJ; Remmers S; Busstra MB; Gan M; Klaver S; Rietbergen JBW; van der Slot MA; Hollemans E; Kweldam CF; Bangma CH; Roobol MJ; van Leenders GJLH
    Histopathology; 2024 Nov; 85(5):760-768. PubMed ID: 39108215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of positive surgical margins on oncological outcome following laparoscopic radical prostatectomy (LRP): long-term results.
    Busch J; Stephan C; Klutzny A; Hinz S; Kempkensteffen C; Kilic E; Lein M; Weikert S; Miller K; Magheli A
    World J Urol; 2013 Apr; 31(2):395-401. PubMed ID: 22576695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gleason grading after neoadjuvant hormonal therapy retains prognostic value for systemic progression following radical prostatectomy.
    Stewart SB; Cheville JC; Sebo TJ; Frank I; Boorjian SA; Thompson RH; Gettman MT; Tollefson MK; Umbriet EC; Psutka SP; Bergstralh EJ; Rangel L; Karnes RJ
    Prostate Cancer Prostatic Dis; 2014 Dec; 17(4):332-7. PubMed ID: 25156060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neoadjuvant hormonal therapy in carcinoma of the prostate.
    Lee HH; Warde P; Jewett MA
    BJU Int; 1999 Mar; 83(4):438-48. PubMed ID: 10210568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of the extent and location of positive surgical margins on the risk of biochemical recurrence following radical prostatectomy in men with Gleason 7 prostate cancers.
    Matti B; Reeves F; Prouse M; Zargar-Shoshtari K
    Prostate; 2021 Dec; 81(16):1428-1434. PubMed ID: 34570379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathological Significances of Positive Surgical Resection Margin after Radical Prostatectomy for Prostatic Cancers: A Meta-Analysis.
    Kim M; Yoo D; Pyo J; Cho W
    Medicina (Kaunas); 2022 Sep; 58(9):. PubMed ID: 36143928
    [No Abstract]   [Full Text] [Related]  

  • 30. Obesity is a predictor in prostate cancer patients receiving prostatectomy after neoadjuvant hormonal therapy.
    Sun L; Xu T; Yuan X; Liu F; Guan F; Ye D; Zhang G
    Tumori; 2020 Apr; 106(2):133-138. PubMed ID: 31451070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction androgen deprivation plus prostatectomy for stage T3 disease: failure to achieve prostate-specific antigen-based freedom from disease status in a phase II trial.
    Gomella LG; Liberman SN; Mulholland SG; Petersen RO; Hyslop T; Corn BW
    Urology; 1996 Jun; 47(6):870-7. PubMed ID: 8677579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The limited significance of a longer duration of neoadjuvant hormonal therapy prior to radical prostatectomy for high-risk prostate cancer in Japanese men.
    Miyake H; Sakai I; Inoue TA; Hara I; Fujisawa M
    Urol Int; 2006; 77(2):122-6. PubMed ID: 16888415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
    Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
    BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinicopathological significance of 114 cases with positive surgical margin in radical prostatectomy specimens].
    Liu LT; Cui D; Wang M; Liu M; Liu DG; Zhang W
    Zhonghua Bing Li Xue Za Zhi; 2022 Jul; 51(7):627-633. PubMed ID: 35785833
    [No Abstract]   [Full Text] [Related]  

  • 35. Learning curve of minimally invasive radical prostatectomy: Comprehensive evaluation and cumulative summation analysis of oncological outcomes.
    Sivaraman A; Sanchez-Salas R; Prapotnich D; Yu K; Olivier F; Secin FP; Barret E; Galiano M; Rozet F; Cathelineau X
    Urol Oncol; 2017 Apr; 35(4):149.e1-149.e6. PubMed ID: 28117215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Linear extent of positive surgical margin impacts biochemical recurrence after robot-assisted radical prostatectomy in a high-volume center.
    Porcaro AB; Tafuri A; Sebben M; Amigoni N; Shakir A; Corsi P; Processali T; Pirozzi M; Rizzetto R; Bernasconi R; Cerrato C; Tiso L; Migliorini F; Novella G; Brunelli M; De Marco V; Siracusano S; Artibani W
    J Robot Surg; 2020 Aug; 14(4):663-675. PubMed ID: 31893344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [8-month neoadjuvant hormonal therapy before radical prostatectomy for high-risk prostate cancer].
    Tabata K; Satoh T; Matsumoto K; Fujita T; Irie A; Iwamura M; Yanagisawa N; Matsuda D; Muramoto M; Kadowaki K; Suyama K; Shoji K; Koh H; Kawakami T; Okayasu I; Egawa S; Baba S
    Nihon Hinyokika Gakkai Zasshi; 2006 Jul; 97(5):712-8. PubMed ID: 16898594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathological effects of neoadjuvant hormonal therapy help predict progression of prostate cancer after radical prostatectomy.
    Kitagawa Y; Koshida K; Mizokami A; Komatsu K; Nakashima S; Misaki T; Katsumi T; Namiki M
    Int J Urol; 2003 Jul; 10(7):377-82. PubMed ID: 12823692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of positive surgical margin location and perineural invasion on biochemical recurrence in patients undergoing radical prostatectomy.
    Lian Z; Zhang H; He Z; Ma S; Wang X; Liu R
    World J Surg Oncol; 2020 Aug; 18(1):201. PubMed ID: 32791998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variation in Positive Surgical Margin Status After Radical Prostatectomy for pT2 Prostate Cancer.
    Tan WS; Krimphove MJ; Cole AP; Marchese M; Berg S; Lipsitz SR; Löppenberg B; Nabi J; Abdollah F; Choueiri TK; Kibel AS; Sooriakumaran P; Trinh QD
    Clin Genitourin Cancer; 2019 Oct; 17(5):e1060-e1068. PubMed ID: 31303561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.